These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 26134064)

  • 1. Ameliorative effects of Nigella sativa on dyslipidemia.
    Asgary S; Sahebkar A; Goli-Malekabadi N
    J Endocrinol Invest; 2015 Oct; 38(10):1039-46. PubMed ID: 26134064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nigella sativa (black seed) effects on plasma lipid concentrations in humans: A systematic review and meta-analysis of randomized placebo-controlled trials.
    Sahebkar A; Beccuti G; Simental-Mendía LE; Nobili V; Bo S
    Pharmacol Res; 2016 Apr; 106():37-50. PubMed ID: 26875640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical and clinical effects of Nigella sativa and its constituent, thymoquinone: A review.
    Gholamnezhad Z; Havakhah S; Boskabady MH
    J Ethnopharmacol; 2016 Aug; 190():372-86. PubMed ID: 27364039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Nigella sativa and Allium sativum coadminstered with simvastatin in dyslipidemia patients: a prospective, randomized, double-blind trial.
    Ahmad Alobaidi AH
    Antiinflamm Antiallergy Agents Med Chem; 2014 Mar; 13(1):68-74. PubMed ID: 23848231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of Nigella sativa (Kalonji) and simvastatin for the treatment of hyperlipidemia and in the induction of hepatotoxicity.
    Muneera KE; Majeed A; Naveed AK
    Pak J Pharm Sci; 2015 Mar; 28(2):493-8. PubMed ID: 25730783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Nigella sativa (black seed) on subjective feeling in patients with allergic diseases.
    Kalus U; Pruss A; Bystron J; Jurecka M; Smekalova A; Lichius JJ; Kiesewetter H
    Phytother Res; 2003 Dec; 17(10):1209-14. PubMed ID: 14669258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidation of mechanisms of actions of thymoquinone-enriched methanolic and volatile oil extracts from Nigella sativa against cardiovascular risk parameters in experimental hyperlipidemia.
    Ahmad S; Beg ZH
    Lipids Health Dis; 2013 Jun; 12():86. PubMed ID: 23758650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Effects of Cucumis sativus Seed Extract on Serum Lipids in Adult Hyperlipidemic Patients: A Randomized Double-Blind Placebo-Controlled Clinical Trial.
    Soltani R; Hashemi M; Farazmand A; Asghari G; Heshmat-Ghahdarijani K; Kharazmkia A; Ghanadian SM
    J Food Sci; 2017 Jan; 82(1):214-218. PubMed ID: 27886382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer activity of Nigella sativa (black seed) and its relationship with the thermal processing and quinone composition of the seed.
    Agbaria R; Gabarin A; Dahan A; Ben-Shabat S
    Drug Des Devel Ther; 2015; 9():3119-24. PubMed ID: 26124636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular benefits of black cumin (Nigella sativa).
    Shabana A; El-Menyar A; Asim M; Al-Azzeh H; Al Thani H
    Cardiovasc Toxicol; 2013 Mar; 13(1):9-21. PubMed ID: 22911452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological and toxicological properties of Nigella sativa.
    Ali BH; Blunden G
    Phytother Res; 2003 Apr; 17(4):299-305. PubMed ID: 12722128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Powdered black cumin seeds strongly improves serum lipids, atherogenic index of plasma and modulates anthropometric features in patients with Hashimoto's thyroiditis.
    Farhangi MA; Dehghan P; Tajmiri S
    Lipids Health Dis; 2018 Mar; 17(1):59. PubMed ID: 29587770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of Nigella sativa seeds for the treatment of hyperlipidemia: a randomized, placebo controlled clinical trial.
    Sabzghabaee AM; Dianatkhah M; Sarrafzadegan N; Asgary S; Ghannadi A
    Med Arch; 2012; 66(3):198-200. PubMed ID: 22822623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The possible protective effects of virgin olive oil and Nigella sativa seeds on the biochemical and histopathological changes in pancreas of hyperlipidaemic rats.
    Aboul-Mahasen LM; Abdulrahman Alshali R
    Folia Morphol (Warsz); 2019; 78(4):762-772. PubMed ID: 30816553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of apolipoprotein A-I gene expression by black seed (Nigella sativa) extracts.
    Haas MJ; Onstead-Haas LM; Naem E; Wong NC; Mooradian AD
    Pharm Biol; 2014 Sep; 52(9):1119-27. PubMed ID: 24635344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of the preclinical pharmacological properties of Nigella sativa (black seeds): a complementary drug with historical and clinical significance.
    Dajani EZ; Shahwan TG; Dajani NE
    J Physiol Pharmacol; 2016 Dec; 67(6):801-817. PubMed ID: 28195061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nigella sativa improves glucose homeostasis and serum lipids in type 2 diabetes: A systematic review and meta-analysis.
    Daryabeygi-Khotbehsara R; Golzarand M; Ghaffari MP; Djafarian K
    Complement Ther Med; 2017 Dec; 35():6-13. PubMed ID: 29154069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red grape seed extract improves lipid profiles and decreases oxidized low-density lipoprotein in patients with mild hyperlipidemia.
    Razavi SM; Gholamin S; Eskandari A; Mohsenian N; Ghorbanihaghjo A; Delazar A; Rashtchizadeh N; Keshtkar-Jahromi M; Argani H
    J Med Food; 2013 Mar; 16(3):255-8. PubMed ID: 23437789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The petroleum ether extract of Nigella sativa exerts lipid-lowering and insulin-sensitizing actions in the rat.
    Le PM; Benhaddou-Andaloussi A; Elimadi A; Settaf A; Cherrah Y; Haddad PS
    J Ethnopharmacol; 2004 Oct; 94(2-3):251-9. PubMed ID: 15325727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Nigella sativa seeds (black cumin) on insulin secretion and lipid profile: A pilot study in healthy volunteers.
    Pelegrin S; Galtier F; Chalançon A; Gagnol JP; Barbanel AM; Pélissier Y; Larroque M; Lepape S; Faucanié M; Gabillaud I; Petit P; Chevassus H
    Br J Clin Pharmacol; 2019 Jul; 85(7):1607-1611. PubMed ID: 30875097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.